Clinical trial Recruiting at 11 sites Observational Ages 53 to 75 Women only

Long-term evaluation of transvaginal mesh for pelvic organ prolapse

Official title: Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study

Run by Peking Union Medical College Hospital · NCT05938881 · Data updated 2026-11-12

This study follows women who had surgery for pelvic organ prolapse to see how well the treatments work and if there are any long-term problems up to 10 years later.

More Pelvic Organ Prolapse trials

Quick facts

Study typeObservational
Ages53 Years to 75 Years
SexWomen only
Enrollment336 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations11 sites (Foshan, Guangdong and 10 other locations)
StatusRecruiting
StartedJune 29, 2023
Main results expectedJanuary 12, 2033
Study endsMarch 12, 2033
Registry record updatedJuly 11, 2023
Trial IDNCT05938881 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women who have previously participated in the original randomized controlled trial.

Probably not a fit

Patients who did not participate in the previous RCT or those unable to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to follow women who previously participated in a randomized controlled trial comparing two surgical techniques for pelvic organ prolapse: the self-cut mesh procedure and the mesh-kit procedure. The focus is on assessing the long-term success and complication rates of these treatments over a period of up to 10 years post-surgery. Participants will be encouraged to engage in annual examinations and telephone surveys to gather comprehensive data on their outcomes. No new interventions will be administered, as this study is solely focused on long-term follow-up of existing participants.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of transvaginal mesh procedures for treating pelvic organ prolapse.

How similar studies have gone: Other studies have explored similar surgical techniques, but this long-term follow-up approach is relatively novel in evaluating the outcomes of transvaginal mesh procedures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women enrolled in previous RCT study

Exclusion Criteria:

* Inability to provide informed consent. Informed consent will be obtained prior to each telephone interview and each in-person visit.
* Subjects who appear to have cognitive deficits during the in-person visit or site telephone interview will be withdrawn from the study by the study coordinator.

Where it's running

  • Foshan Maternal and Child Health Care Hospital
    Foshan, Guangdong, China
    Recruiting
  • The First Affiliated Hospital of Guangdong Medical College
    Guangzhou, Guangdong, China
    Recruiting
  • Changsha Maternal and Child Health Care Hospital
    Changsha, Hunan, China
    Recruiting
  • The Secong Xiangya Hospital of Central South University
    Changsha, Hunan, China
    Recruiting
  • Wuxi Maternal and Child Health Care Hospital
    Wuxi, Jiangsu, China
    Recruiting
  • Qilu Hospital of Shandong University
    Jinan, Shandong, China
    Recruiting
Show 5 more locations
  • Shanxi Provincial People's Hosptial
    Xi’an, Shanxi, China
    Recruiting
  • Sichuan University West China Second University Hospital
    Chengdu, Sichuan, China
    Recruiting
  • the First Affiliated Hosptial of Xinjiang Medical University
    Ürümqi, Xiangjiang, China
    Recruiting
  • The People's Hospital of Xinjiang Uygur Autonomous Region
    Ürümqi, Xinjiang, China
    Recruiting
  • Peking Union Medical College Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.